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Abstract
Trypanosoma cruzi is the causative agent of Chagas’ disease. Novel chemotherapy with the drug K11777 targets the major
cysteine protease cruzain and disrupts amastigote intracellular development. Nevertheless, the biological role of the
protease in infection and pathogenesis remains unclear as cruzain gene knockout failed due to genetic redundancy. A role
for the T. cruzi cysteine protease cruzain in immune evasion was elucidated in a comparative study of parental wild type-
and cruzain-deficient parasites. Wild type T. cruzi did not activate host macrophages during early infection (,60 min) and
no increase in ,Pi kB was detected. The signaling factor NF-kB P65 colocalized with cruzain on the cell surface of
intracellular wild type parasites, and was proteolytically cleaved. No significant IL-12 expression occurred in macrophages
infected with wild type T. cruzi and treated with LPS and BFA, confirming impairment of macrophage activation pathways.
In contrast, cruzain-deficient parasites induced macrophage activation, detectable ikB phosphorylation, and nuclear NF-kB
P65 localization. These parasites were unable to develop intracellularly and survive within macrophages. IL 12 expression
levels in macrophages infected with cruzain-deficient T. cruzi were comparable to LPS activated controls. Thus cruzain
hinders macrophage activation during the early (,60 min) stages of infection, by interruption of the NF-kB P65 mediated
signaling pathway. These early events allow T. cruzi survival and replication, and may lead to the spread of infection in acute
Chagas’ disease.
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Introduction
Trypanosoma cruzi is the parasitic agent of Chagas’ disease that
affects approximately 12 million people throughout Latin America
(WHO). Current chemotherapy with nifurtimox and benznidazole
is unsatisfactory due to severe side effects that require medical
supervision [1–3]. T. cruzi infection is classically transmitted by an
insect vector, the reduviid bug [4]. Parasites disseminate from the
insect bite site and, in the most common clinical course of Chagas’
disease, infect cardiac myocytes leading to acute myocarditis or
chronic infection with relentless cardiac failure. Fulminant disease
is commonly seen with HIV infection or immunosuppression. In
patients with immunodeficieny, parasites may be found in many
organs, and a highly fatal meningoencephalitis often ensues. These
observations led us to hypothesize that T. cruzi successfully evades
the host immune response, and may in fact utilize unresponsive
macrophages as a means of egress from the insect bite site prior to
dissemination to other cell types [5]. While the specific
mechanisms of immune evasion by T. cruzi remain largely
unknown, several reports have suggested that the major protease
of T. cruzi, cruzain, (a.k.a. cruzipain, GP57/51) is a key factor [6,7].
Cruzain plays a biological role in cell remodeling during
transformation of the insect epimastigote stage of T. cruzi to
infectious metacyclic [8–11]. Scharfstein and collaborators found
cruzain involvement during trypomastigote infection by the
proteolytic release of kinin from host cells surfaces and activation
of bradykinin receptors [12–14]. More recent reports suggested
that cruzain mediates anti-apoptotic mechanisms in T. cruzi-
infected myocardiocytes in vitro [15]. The biological role of cruzain
in the intracellular amastigote stage of T. cruzi and in Chagas’
disease pathogenesis remains nevertheless largely unknown.
Assessments of the role of cruzain in T. cruzi pathogenicity have
been hampered by genetic redundancy and the failure of gene
deletion attempts [9,12,16,17]. Successful knockout of the cruzain
gene cluster has not been achieved to date leading to speculation
that deletion of the cruzain coding genes might be lethal.
Chemical knockout with cysteine protease inhibitors was also
lethal for T. cruzi [18]. Although the role of auto-proteolysis in
cruzain activation was confirmed, these studies did not allow
elucidation of the biological role of this protease in human disease.
Duschak et al. [19,20] observed lower cruzain activity and protease
sequence alterations in attenuated strains as compared to their
virulent parental T. cruzi, while other authors found infectivity is
not dependent on cruzain expression or activity [21]. An
alternative approach to study the biological role of this vital gene
product is to examine the phenotype of protease-deficient
organisms. We generated a protease deficient T. cruzi that retained
less than 1% of cruzain activity of the wild type parental clone
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host macrophages via NF-kB P65 and are unable to survive
intracellularly within macrophages. In contrast, infection with wild
type parasites appears to induce cruzain-mediated proteolysis of
NF-kB P65 leading to unresponsiveness of the host macrophage
during early (,60 minutes) infection. This immune evasion
mechanism may be critical for T. cruzi survival during early
natural infection with a low number of trypmastigotes.
Materials and Methods
Parasites and cells
Wild type CA-I/72 T. cruzi was isolated from an Argentinean
chronic chagasic patient and cloned [23]. Cruzain-deficient, and
cysteine protease inhibitor (K11777)-resistant (CA-I/KR; KR) T.
cruzi were derived from parental CA-I/72 parasites [22]. The
cysteine protease inhibitor K11777 (K777, N-Methyl-Pip-F-hF-
VSW) was kindly provided by J. Palmer, Celera, CA [18,24].
Epimastigotes were maintained at 26uC in Brain-heart tryptose
(BHT) medium [25] with 10% heat inactivated fetal calf serum
(FCS), and with the addition of 20-fold the lethal dose (200 mM) of
K11777 for phenotypic cruzain-deficient CA-I/KR.
Bovine embryo skeletal muscle cells (BESM) cells were a kind
gift of J. A. Dvorak, NIH. Mammalian stages of wild type (WT)
CA-I/72 were maintained in BESM cells with RPMI-1640
medium and 5% heat inactivated horse serum (HS) at 37uC
[26]. Intracellular cruzain-deficient CA-I/KR T. cruzi were
maintained serially in BESM as above but with the addition of
5% heat inactivated FCS, 5% heat inactivated horse serum, and
10 mM K11777. Long-term culture at higher concentrations of the
inhibitor was toxic for BESM cells. For some experiments, the
mammalian stages of cruzain-deficient CAI/KR were also
cultured for 4 passages (2 months) in the absence of inhibitor.
The approximate duration of the intracellular cycle of wild type
CA-I/72 (4.5 days) [23] and CA-I/KR (18 days) was estimated in
infected BESM cells by contrast phase microscopy and by
fluorescence microscopy of propidium iodine stained slides.
Cruzain-deficient parasites were unable to survive and develop
within macrophages.
J774 mouse macrophages were from the UCSF cell culture
facility. J774 cells were cultured as above and in some experiments
irradiated (1000 Rad) 24 h prior to use to arrest cell division.
Normal peritoneal macrophages were collected from C3H mice
(The Jackson Lab).
Ethics statement
This study was carried out in strict accordance with the Guide
for the Care and Use of Laboratory Animals of the National
Institutes of Health. The protocol was approved by the
Institutional Animal Care and Use Committee of the University
of California, San Francisco (AN079928-02A).
Protease labeling
WT and cruzain-deficient epimastigotes were washed three
times in PBS, counted in a Coulter Counter Multisizer 3
(Beckman) and taken to equal numbers of parasites/ml, lysed by
5 cycles of freeze-thawing, centrifuged at 14,000 xg for 1 h at 4uC
[22], and frozen at 270uC until used. Fractions (10
5 epimasti-
gotes/lane) were reacted with the iodinated inhibitor DCG04
[27,28] and electrophoresed. Resolved molecular species were
then isolated and analyzed by nano LC/MS, CID spectra, and/or
fractionation by MALDI-TOF at the Protein Facility, UCSF.
Protein fragments (9-17 aa long) were analyzed by NCBI blast.
Immunoelectron microscopy (IEM)
BESM cells infected with intracellular amastigotes of WT or
cruzain-deficient T. cruzi were processed for IEM with a specific
anti-cruzain polyclonal antibody as previously described [24].
Briefly, T. cruzi-infected BESM cells were collected by centrifuga-
tion, washed twice with PBS and fixed for 2 hours at 4uC with 2%
paraformaldehyde-0.05% glutaraldehyde in 0.1 M phosphate
buffer, pH 7.4. Cells were then cryoprotected, frozen, sectioned,
and immunolabeled sequentially with rabbit polyclonal anti-
cruzain Ab and goat anti-rabbit IgG-10 nm gold-labeled Ab
(dilutions 1:250 and 1:500, respectively). Thin sections were
observed in a Tecnai 10 (FEI Co.) electron microscope. Gold-
labeled cruzain localizing to the amastigote cell surface was
quantified in micrographs of intracellular parasites in three
independent experiments (n=55 wild type amastigotes; n=55
cruzain-deficient amastigotes). The cell perimeter of sectioned
intracellular amastigotes was measured with Openlab software
(Improvision), and cruzain density was expressed as the number of
gold labeled cruzain particles/mm of parasitic cell membrane.
Results were statistically analyzed (t test).
Western blots (WB)
J774 macrophages were seeded onto 12 well tissue culture plates
for 24 h prior to infection with WT or cruzain-deficient T. cruzi as
appropriate. Infection was performed at a low ratio of 0.5
parasites/macrophage. Some infected cultures were treated with
cysteine protease inhibitor. Controls consisted of J774 macrophage
cultures that were uninfected, treated with purified LPS (150 ng/
ml LPS, Sigma) [29], or treated with K11777. Samples were
collected at 1 min, 30 min, 60 min, and 150 min, and at 48 h
post-infection. Monolayers were washed twice with cold PBS,
solubilized in 1 ml cold PBS with1% Triton X-100, scraped,
aliquoted, immediately snap-frozen, and stored at 270uC until
used. Samples were centrifuged at 14,000 xg for 30 min at 4uC
and supernatants taken to identical protein concentration.
Samples (1 mg protein/lane) were heated at 70uC for 5 min and
resolved by Nupage electrophoresis (10% BisTris gels at 200 V,
Mops Buffer) (Novex, Invitrogen) prior to transferring to PVDF
membranes (35 V for 2 h). Blots were blocked overnight with 1%
BSA (Sigma). Samples were blotted with rabbit anti–NF-kB P65
Ab, rabbit anti- ikB Ab, mouse anti-phosphorylated (,P) ikBA b
(Santa Cruz Biotech, CA) and anti actin Ab (Cal Biochem). All
methods were according to manufacturer’s instructions (Santa
Cruz Biotech, CA). Additional controls were similarly infected
Author Summary
Trypanosoma cruzi (T. cruzi) is the unicellular parasite that
causes Chagas’ disease, a devastating health burden
throughout Latin America now also affecting developed
countries. Macrophages are the first cells that become
infected by T. cruzi and disseminate the infection to other
tissues. The parasite then preferentially infects and
multiplies within heart muscle cells causing severe heart
disease and often death. The new drug K11777 targets a
vital parasite enzyme, the protease cruzain. Consequently,
it is important to understand what the enzyme is doing
during infection. To elucidate the role of the protease, we
compared infection of macrophages with parental wild
type parasites and with protease deficient T. cruzi. We now
report a role for the parasitic protease in immune evasion.
The protease prevents macrophage activation thus allow-
ing T. cruzi survival and replication, and favoring the
spread of infection.
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Glasgow, UK), for 48 hours. Results were confirmed in duplicate
experiments according to methods described by Ma and
colleagues [30–32]. Briefly, 5610
6 cells per point (1, 10, 30, and
60 min) were infected with T. cruzi trypomastigotes as above (ratio
0.5 parasites/cell). Non-infected macrophages either untreated
(MW) or treated with LPS, and/or K11777 as indicated (10, 20, 40
and 60 min) were also used as controls. Macrophages were washed
twice with PBS, scraped, transferred to eppendorf tubes, and
centrifuged prior to lysis with NP40 lysis buffer (0.1% NP40,
1 mM Na vanadate and 5 mM Na fluoride250 mM HEPES).
Nuclei were then pelleted by centrifugation (20 min at 14,000 xg,
4uC) and discarded, and the supernatants were boiled in Laemli
buffer for 10 min immediately prior to SDS-PAGE/WB (Cell
Signalling Technology) [30,31]. Membranes were developed
sequentially with anti ,PikB Ab (Cell Signalling), anti-ikBA b
(Cell Signalling), and anti-actin Ab (Southern Biotech) [30].
Confocal microscopy
Duplicates of samples described above for WB and appropriate
controls were simultaneously seeded onto 12 well tissue culture
plates containing sterile round cover glasses. At 1 min, 30 min,
60 min, and 150 min post-infection, cells were washed, fixed with
fresh 4% paraformaldehyde in PBS, rinsed in PBS, treated with
0.1% Triton X-100 in PBS for 5 min, rinsed, and processed for
confocal microscopy with anti -mouse NF-kB P65Ab (Dil 1/100;
Santa Cruz Biotech, CA) followed by Alexa 488 labeled secondary
Ab and propidium iodine (Molecular Probes). Results are from 3–
7 independent experiments (n=2–3 slides per treatment).
Confocal images were acquired with a Leica Laser Confocal
microscope TCS-NP, using Leica software and identical param-
eters for all samples, namely, a 100X objective with a numerical
aperture of 1.4 in a 102461024 format, a pinhole of 0.7 airy, and
a Z section of 0.2 mm.
For colocalization studies of cruzain and NF-kB P65, macro-
phages infected for 30 min with WT T. cruzi and treated or not
with K11777, or similarly infected with cruzain-deficient T. cruzi
and treated or not with K11777, and non-infected controls were
fixed and stained sequentially with rabbit anti-NF-kB P65 Ab (Dil
1/100; Santa Cruz Biotech) and Alexa 488-labeled secondary Ab,
followed by rabbit polyclonal anti-cruzain antibody (Dil 1/100)
[24] previously labeled with Alexa 594 according to manufactur-
er’s instructions (Molecular Probes).
For confocal studies of IL12 expression, macrophages treated or
not with K11777 were infected with WT or cruzain-deficient T.
cruzi for 1 h (ratio 0.5 trypomastigotes/macrophage) followed by
overnight incubation with fresh RPMI medium at 37uC. Cultures
were then exposed to 150 ng/ml purified LPS for 2 h (Sigma),
followed by 5 mg/ml BFA (Molecular Probes) for 1 h at 37uC.
Appropriate controls were included in three independent exper-
iments (n=2 per sample). Slides were then fixed as above, and
simultaneously stained with anti-IL12 antibody (1/100) (R&D
Systems) [33] for 1 h followed by secondary Cy2-labeled
secondary Ab (dil 1/1000) (Biomed) and propidium iodine (PI)
(Dil 1/5000) (Molecular Probes). Coverslips were mounted with
Vecta-Shield (Vector Lab). All slides were observed and
documented on the same day in a Leica microscope, model
TCS-NP, using Leica software and identical confocal parameters
as described above. The microscopist analyzed all slides blindly.
Fluorescence was then analyzed quantitatively with Openlab
software (Improvision). Fluorescence intensity was recorded at
random (n=12 per sample) and statistically analyzed (t test).
For other additional studies, macrophages infected with WT
and cruzain-deficient CA-I/KR, and uninfected controls were
stained with a macrosialin (mouse CD68 homolog) specific Ab
(Serotec) (Dil 1/200) followed by a CY2 affinity-pure donkey anti-
rat IgG (Jackson Immuno-Research lab) secondary Ab and PI
(Molecular Probes).
Proteolysis of NF-kB P65
Human recombinant NF-kB P65 (rNF-kB P65) (Active Motif,
Japan) expressed in E. coli from a full-length cDNA clone has a 14
aa deletion at the C-term. One ml of rNF-kB P65 was diluted to
150 nM in 10 ml of 1x buffer (with 5 ml 1M DTT/ml or 5 mM
DTT) and reacted or not with recombinant cruzain at 150 nM (1/
1) and serial dilutions (1/10 to 1/1000) in 100 mM Na Acetate
Buffer pH 5.5 for 2 h at 37uC. Human rNF-kB P65 was also
reacted with sonicates from 2.5610
5 wild type CA-I/72 or cruzain
deficient CA-I/KR parasites as above. Samples were then resolved
by WB as above with anti- NF-kBP65 Ab.
T. cruzi in vitro assay
To better understand the effect of macrophage activation on
parasite intracellular development, macrophages were infected
with WT T. cruzi (ratio 0.5 trypomastigotes/cell) for 1 h at 37uC.
Cultures included untreated controls, and macrophages treated
with 150 nM purified LPS [29] as follows: LPS was added 1 h
prior to T. cruzi infection, concomitantly with infection, or 1 h
after infection. Cultures were treated with LPS for up to 48 h.
Duplicate cultures were fixed with 4% paraformaldehyde at 1 h
(to), 24 h, and 48 h post-infection. Cells were stained with PI and
the mean number of intracellular parasites/cell was estimated in
200 cells per slide (n=3 slides/treatment) in two independent
experiments [26]. Results were analyzed statistically (t test).
Cruzain and L-arginase assays
Cruzain activity was determined in extracts of WT and cruzain-
deficient CA-I/KR epimastigotes as previously described [22]. For
L-arginase determinations [7,34], J774 uninfected controls and
macrophages infected with WT or cruzain-deficient trypomasti-
gotes were used. Cells were collected 48 h post-infection and
samples fixed in 4% paraformaldehyde for counting in a Coulter
Counter Multisizer 3 (Beckman). Aliquots corresponding to
10
5cells/50 ml were prepared by duplicate for L-arginase assays
as described by Stempin et al. [7] Briefly, cells were lysed in 0.1%
Triton X-100 buffer with protease inhibitors, centrifuged at
14,000 xg for 30 min at 4uC, and supernatants stored at 270uC.
L-arginase activity in supernatants was determined as described
[7,34]. Urea (mg/ml) was measured at 540 nm. Results from three
independent experiments (n=3 per sample) were analyzed
statistically with Prism 4 software.
Results
Cruzain-deficient T. cruzi
The cysteine protease inhibitor K11777 is cidal for WT T. cruzi.
By exposing CA-I/72 T. cruzi to gradual step-wise micromolar
increases in K11777 concentration over a period of 2 years, we
generated a K11777-resistant and cruzain-deficient T. cruzi that
retains negligible (,1%) protease activity as detected by a
fluorescent protease substrate [22]. Both parental WT and
cruzain-deficient parasites are clonal populations [22]. Cruzain-
deficient T. cruzi have remained resistant to K11777 for 14 years
even after passage through animals. The mechanism of drug
resistance has been described in epimastigotes and is due to
secretion of inactive, unprocessed cruzain [22]. The IC50 for CA-
I/72 epimastigotes is 3–5 mM K11777 while cruzain-deficient
epimastigotes are routinely maintained in 20-fold the lethal dose of
T. cruzi Protease Mediates Immune Evasion
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cruzain-deficient amastigotes are 0.8–1 mM and 12 mM K11777,
respectively.
Differing from parental CA-I/72 T. cruzi that are lethal at
doses of $10
3 trypomastigotes, cruzain-deficient parasites are
unable to establish infection in normal mice even at doses of 10
6
trypomastigotes and are only lethal in a severely immunodeficient
Rag 1 2/2 mouse model of Chagas’ disease (Doyle, unpublished
data). These results will be independently submitted for
publication.
An active site affinity tag identifies processed active
proteases of wild type and cruzain deficient T. cruzi
To identify and compare proteases in WT and cruzain-deficient
T. cruzi, we used a functional proteomic method developed to
profile protease targets in crude cellular extracts [27,28]. The
iodinated probe DCG04, allowed the specific identification of
mature, active cruzain only in parental WT epimastigotes
following SDS-PAGE (Figure 1). Cruzain-deficient parasites
expressed unprocessed inactive cruzain with the prodomain
attached as previously shown by WB [22] but no active mature
protease. The identity of cruzain was confirmed by MS/MALDI
and NCBI blast.
To confirm decreased cruzain expression also in the intracel-
lular pathogenic amastigote stage we performed comparative,
quantitative IEM. A statistically significant (p,0.1) three-fold
decrease in expression of membrane bound cruzain was confirmed
for intracellular cruzain-deficient amastigotes as compared to WT
controls (Figure 2).
Transcription factor NF-kB P65 is only activated in
macrophages infected with cruzain-deficient parasites
It has been proposed that proteases of L. mexicana cleave NF-kB
to facilitate immune evasion [35]. We therefore assayed NF-kB
activation in cells recently (#60 min) infected by cruzain deficient
parasites. We compared macrophage activation signaling path-
ways [36–39] as a consequence of early infection with WT versus
cruzain-deficient T. cruzi. The infection of a cell population by T.
cruzi follows a binomial distribution, with few cells very heavily
infected while most cells remain non-infected. Moreover, infection
with a high ratio of parasites per cell results in premature rupture
of heavily infected macrophages. To prevent the premature release
of intracellular parasites that may secondarily activate macro-
phages in the population, we used a very low infection ratio of 0.5
parasites per cell.
To detect macrophage activation, we performed WB targeting
an NF-kB family member and its specific inhibitor [40–45].
Similar results were obtained with two methods and Abs from the
two different vendors. WB analyses with anti-NF-kB P65 Ab
(Figure 3A) showed expression in macrophages infected with WT
T. cruzi at 1 min and 30 min post-infection (lanes 1, 4) was similar
to uninfected controls (lane 3), and lower (lane 8) at 60 min post-
infection. Phosphorylation of ikB is indicative of cell activation
[40,45]. Samples for WB were either heated to 70uC for 5 min
(Santa Cruz Biotech. methods) or boiled for 10 minutes
immediately prior to SDS-PAGE to dissociate complexes [30–
32]. Samples blotted with specific anti ,PikB Abs from different
commercial sources and using different protocols confirmed
negligible ,Pi kB indicative of unresponsiveness in macrophages
infected with WT T. cruzi for up to 60 min and uninfected controls
(Figure 3B). In contrast, ,Pi kB indicative of activation was
confirmed in macrophages infected with cruzain-deficient T. cruzi
as early as 1 min post-infection. Additional macrophage controls
infected with cruzain-deficient T. cruzi cultured for 2 months
without K11777 showed intermediate results as these parasites
only regained partial cruzain activity, and were not investigated
further [22]. Additional controls were uninfected macrophages
treated or not with LPS and/or K11777 (K77) (Figure 3D). In L.
mexicana infected controls [32], NF-kB P65 degradation was still
observed 48 h post-infection (data not shown).
NF-kB is translocated to the nucleus only in
macrophages infected with cruzain-deficient parasites
To further investigate macrophage responses to WT versus
cruzain deficient T. cruzi-infection, we performed confocal studies.
NF-kB P65 localization was cytoplasmic in macrophage controls
(Figure 4E). NF-kB P65 localization was also cytoplasmic in
macrophages infected with WT T. cruzi for 1, 30, and 60 min post-
infection confirming unresponsiveness to T. cruzi infection.
Interestingly, NF-kB P65 covered the surface of WT amastigotes
as early as 30 min post-infection (Figure 4A–B). Similar results
were observed in BESM cells and thioglycolate elicited peritoneal
mouse macrophages (data not shown). In contrast, intense NF-kB
P65 label indicative of cell activation localized to the nucleus of
macrophages infected with cruzain-deficient T. cruzi (Figure 4C–
D) (yellow fluorescence), and no NF-kB P65 was seen bound to
parasites for up to 60 min. Activation also occurred in macro-
phage controls infected with WT T. cruzi in the presence of 10 mM
K11777 (data not shown).
Colocalization of NF-kB and cruzain
Colocalization of NF-kB P65 (green fluorescence) and cruzain
(red fluorescence) on the cell surface of intracellular parasites
occurred in macrophages infected with WT T. cruzi even during
Figure 1. An active site affinity tag identifies processed active proteases of wild type and cruzain deficient T. cruzi. Iodinated DCGO4
(0.1, 1, 10, and-50 mM) was reacted with epimastigote extracts (10
5 epimastigotes/lane). Processed, active cruzain (47.5 kD) was identified as the
major protease in wild type T. cruzi. Higher molecular species identified as unprocessed cruzain by MALDI but no active protease were observed in
cruzain-deficient parasites at 50 mM DCG04.
doi:10.1371/journal.ppat.1002139.g001
T. cruzi Protease Mediates Immune Evasion
PLoS Pathogens | www.plospathogens.org 4 September 2011 | Volume 7 | Issue 9 | e1002139Figure 2. IEM confirms lack of surface-associated cruzain. A cruzain-specific gold-labeled secondary antibody identified cruzain on the cell
surface of intracellular wild type and cruzain-deficient T. cruzi amastigotes. A 3-fold (p,0.1) reduction in gold-labeled Ab detection of cruzain was
present on the cell surface and flagellar pocket of cruzain-deficient CA-I/KR (B) versus wild type amastigotes (A) (45,000X). Results are representative
of three independent experiments. N, nucleus; K, kinetoplast; FP, flagellar pocket; C, cytoplasm of BESM cell.
doi:10.1371/journal.ppat.1002139.g002
Figure 3. Cruzain-deficient (KR) but not WT parasites activate NF-kB. Uninfected controls and mouse macrophages (MW) infected with WT
or KR T. cruzi were infected for # 1 min (lanes 1, 2), 30 minutes (lanes 3–7) and 60 minutes (lanes 8–11). Cell extracts were western blotted with:
A, anti-NF-kB P65 Ab; B, anti ,P-ikB; C, anti-actin Ab. MW were infected as follows: lane #1, WT; lane #2, KR; lane #3, uninfected MW; lane #4, WT;
lane #5, KR; lane #6, KR with 10 mM K11777; lane #7, KR cultured without K777 for 2 months; lane #8, WT; lane #9, KR; lane #10, KR with 10 mM
K11777; lane #11, KR cultured without K11777 for 2 months. Results are representative of six independent experiments using two different methods.
Controls (D) were MW treated or not with K11777 and/or LPS.
doi:10.1371/journal.ppat.1002139.g003
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PLoS Pathogens | www.plospathogens.org 5 September 2011 | Volume 7 | Issue 9 | e1002139Figure 4. NF-kB P65 localizes to the cell surface of wild type parasites. Localization of NF-kB P65 (green fluorescence) was investigated in
mouse macrophages. Parasite and host cell DNA was labeled with PI (red). Non-infected macrophages showed an evenly scattered distribution of
cytoplasmic NF-kB P65 (E). Intracellular WT- T. cruzi appeared coated with macrophage NF-kB P65 (A, B). In contrast, abundant cytoplasmic (green
fluorescence) and nuclear (yellow fluorescence) NF-kB P65 occurred in macrophages infected with cruzain deficient T. cruzi (C–D). Macrophages were
infected for 30 min (A, C), and 60 min (B, D). Results are representative of four independent experiments.
doi:10.1371/journal.ppat.1002139.g004
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Intracellular WT T. cruzi treated with the trypanocidal inhibitor
K11777 for 30 min showed marked cruzain accumulation
presumably in the parasitic Golgi compartment [24] and no
recruitment of NF-kB P65 to the parasite surface (Figure 5D,
arrow).
Proteolysis of human rNF-kB by cruzain
Human rNF-kB P65 was proteolytically cleaved into two major
fragments by native cruzain expressed by WT (Figure 6) but not by
proteases expressed by cruzain-deficient T. cruzi. Similarly,
recombinant cruzain degraded human r-P65 at equimolar
concentrations under the experimental conditions used but not
in the presence of 10 mM K11777.
T. cruzi development in macrophages
To understand the effect of macrophage activation [37,42] on
T. cruzi intracellular survival and development, we performed
quantitative in vitro assays [26]. T. cruzi divided normally in control
macrophages and the mean number of parasites per cell (P/cell)
increased from ,0.5 at to to 2.8 at 48 h (Figure 7) [23]. Activation
of macrophages with purified LPS 1h prior to or concomitantly
with infection resulted in parasite death. T. cruzi developed well in
macrophages treated with LPS 1h post-infection; the lower mean
P/cell probably results from death of parasites still trapped within
the parasitophorus vacuole when activation occurred. Thus
macrophage unresponsiveness in early infection (,60 min) is
crucial for parasite survival and intracellular development.
IL12 expression
To confirm macrophage unresponsiveness to infection with WT
T. cruzi infection, we next investigated IL12 expression by confocal
microscopy followed by fluorescence quantification with Improvi-
sion software. Macrophages infected with WT T. cruzi, and
subsequently activated with LPS followed by BFA treatment,
showed negligible cytoplasmic IL12 (Figure 8A). A significant
increase (P,0.1) in IL12 accumulation occurred in macrophages
infected with wild type T. cruzi and treated with the inhibitor
K11777 that prevents cruzain activity (Figure 8B). Similarly,
activation and significant IL12 accumulation occurred in macro-
phages infected with cruzain-deficient T. cruzi (Figure 8C).
L- arginase assays
Other investigators have reported increased L-arginase activity
induced by cruzain treatment of cells [7]. Only WT parasites
induced 2-5 fold higher L-arginase activity in host macrophages
while cruzain-deficient parasites failed to increase enzymatic
activity (P,0.01). Representative values from one of 3 indepen-
dent experiments are 3.1360.02 mg urea/ml for macrophages
infected with WT parasites, 1.5660.02 mg urea/ml for macro-
phages infected with cruzain-deficient parasites, and 1.560.01 mg
urea/ml for uninfected macrophages.
Discussion
A complex and dynamic scenario of host cell-parasite
interactions is becoming apparent as pathogens use different
mechanisms to subvert host-cell signaling pathways or modulate
their kinetics during intracellular development. Several reports
show that T. cruzi modulates signaling pathways in mammalian
cells [15,43,44]. Some authors propose that activation of NF-kB
proteins may modulate tissue specificity, as muscle cells that
preferentially harbor T. cruzi do not become activated [37] while
others detect muscle and endothelial cell activation post-infection
Figure 5. Colocalization of cruzain and NF-kB P65. A–C. Representative examples of colocalization of labeled cruzain (A) (red fluorescence) and
NF-kB P65 (B) (green fluorescence) in the flagellar pocket region and/or cell surface of interiorized transforming parasites (C, merge). D. Lack of
colocalization of accumulated cruzain (red fluorescence) and NF-kB P65 (green) in a macrophage infected as above with WT T. cruzi and treated with
10 mM K11777 that induces accumulation of unprocessed zymogen in the Golgi compartment (arrow) (22).
doi:10.1371/journal.ppat.1002139.g005
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cruzain during early infection (,60 min) of macrophages by T.
cruzi, and in particular on the nuclear factor NF-kB P65, using the
inhibitor K11777 and phenotypic cruzain knockouts [22].
A major role of the NF-kB family is the regulation of aspects of
the innate and adaptive immune responses. NF-kB members
control the transcription of genes encoding cytokines and
antimicrobial molecules, as well as genes regulating cell differenti-
ation, survival, proliferation and apoptosis [38]. The complex
response depends on the cell type and on the nature, duration and
intensity of the activating signal. NF-kB complexes are normally
inactive in the cytoplasm and uponactivation they enter the nucleus
to modulate gene expression. Membrane receptors (e.g. TRL) and
other signaling regulators are also involved [38–42,43–52].
To compare infection with WT versus cruzain-deficient T. cruzi,
we performed WB of NF-kB P65 and ,Pi kB (Figure 3) [39,47]
that showed unresponsiveness of macrophages infected with WT
parasites. Confocal studies showed that WT parasites rapidly
sequestered NF-kB P65 onto their cell surface (Figure 4, A–B).
Similar events occurred during early infection of peritoneal mouse
Figure 6. Proteolytic cleavage of r-human NF-kB P65 by wild type- and r-cruzain but not by proteases expressed by cruzain-
deficient T. cruzi. Recombinant human NF-kB P65 was treated or not with cruzain or parasite extracts. Lane 1, untreated control; lane 2, r-cruzain
(1:1 molar ratio); lanes 3–4: dilutions 1:10 and 1:100 of r-cruzain, respectively; lane 5, r-cruzain (1:1 molar ratio) and 10 mM K11777; lane 6, WT cruzain;
lane 7, proteases in cruzain-deficient T. cruzi. Results are representative of two independent experiments.
doi:10.1371/journal.ppat.1002139.g006
Figure 7. Macrophage activation prevents T. cruzi intracellular development. Mouse macrophages were infected with wild type T. cruzi and
LPS was added as indicated. Mean parasites/cell were determined at 1 h and 48 h post-infection. Parasite death occurred when LPS was added prior
to and concomitantly with T. cruzi trypomastigotes. Results are representative of two independent experiments (n=3 per treatment).
doi:10.1371/journal.ppat.1002139.g007
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to the cell surface of WT intracellular amastigotes (Figure 2) [53]
and colocalized with NF-kB P65 (Figure 5). Treatment with
K11777 caused accumulation of unprocessed and inactive
protease in the Golgi [24] and abrogated NF-kB P65 sequestration
by the parasite (Figure 5D). Degradation of NF-kB P65 was noted
60 min after infection with wild-type T. cruzi (Figure 3) and native
cruzain degraded recombinant nuclear factor (Figure 6). More-
over, inhibition of IL12 confirmed macrophage unresponsiveness
in early WT T. cruzi infection (Figure 8A).
In contrast, macrophages infected with cruzain-deficient T. cruzi
became rapidly activated via NF-kB P65 (Figure 3, KR) and
intense nuclear localization of P65 occurred shortly after infection
(Figure 4C–D) highlighting a role for cruzain in the modulation of
host cell signaling pathways. As anticipated, infection with cruzain-
deficient parasites induced IL12 accumulation (Figure 8C).
Preventing macrophage activation is crucial for a successful
infection. Indeed, wild type T. cruzi were killed when macrophages
were activated with LPS prior to or during infection (Figure 7),
presumably while parasites are still contained within the parasito-
phorus vacuole [54–57] and are susceptible to cidal macrophage
products. Other macrophage metabolic pathways were also modu-
lated by T. cruzi. Infection with WT but not cruzain-deficient T. cruzi
significantly increased L-arginase activity [6,7]. A similar phenome-
non occurs during Leishmania infection [58]. We also observed down-
modulation of macrosialin, the murine analog of human CD68, in
cells infected with WT T. cruzi (not shown). Further studies may
identify other host cell molecules modulated by T. cruzi [59–63].
Experimental and clinical evidence shows a correlation between
the severity of Chagas’ disease and the persistence of T. cruzi
within tissues [64–65]. NF-kB complexes are important for the
development and function of both innate and adaptive immune
responses triggered by pathogens [38,51]. Metabolic pathways of
the innate immune system induced in early infection have
important consequences in the evolution of the disease as they
play a role in the control of T. cruzi replication, tissue distribution
and degree of parasitism. As infection progresses, an adaptive
immune response develops with production of high levels of
inflammatory cytokines, IFNc and NO radicals [38,59,66–71]. In
the case of T. cruzi, TLR2 and TLR9 receptors mediate cellular
activation [43,59,66,72–73].
Our results show that macrophages infected with WT T. cruzi
remained unresponsive in early infection, and support the
hypothesis that intracellular pathogens are uniquely protected from
macrophage activation [38]. Confirming our results, expression
profiling of bone marrow macrophages infected with T. cruzi
revealed very few transcriptional changes during the first 12 hours.
At 24 hours post infection, both macrophages and fibroblasts
express some interferon-regulated genes [62,74,75]. The L. mexicana
cruzain homologue, ‘‘cpb’’, likewise degrades NF-kBP 6 5 ,I kBa,
and IkBbpreventing macrophage activation [35]. Similar strategies
to suppress immune responses have been found in the coccidian
parasite Theileria [76], and in poliovirus and other picornavirus as
viral proteases cleave NF-kB P65 generating inactive products [77].
We then hypothesize that cruzain plays a key role by degrading NF-
kB P65 and hindering activation of innate phagocytes recruited to
the bite site [5]. Macrophage unresponsiveness would favor parasite
survival in early infection and delay the onset of the immune
response. A successful macrophage infection results in the
production of hundreds of infectious T. cruzi. For example a single
CA-I/72 parasite originates ,130 infectious trypomastigotes in just
4.5 days [23]. Once the host immune response is triggered on [65–
67], parasite development would be restricted to permissive tissues
such as muscle cells [37,71]. Thus cruzain may function during the
early events of macrophage infection favoring immune evasion by
T. cruzi.
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